| Date Filed | Type | Description |
| 10/12/2023 |
10-K
| Annual Report for the period ended August 31, 2023 |
| 10/12/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10% stake in Walgreens Boots Alliance Inc. |
| 08/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Delayed Draw Term Loan Credit Agreement, by and among Walgreens Boots Alliance, Inc., the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent",
"Three-Year Revolving Credit Agreement, by and among Walgreens Boots Alliance, Inc., the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent and Swing Line Lender" |
|
| 08/07/2023 |
SC 13D/A
| Walgreens Boots Alliance, Inc. reports a 15.8% stake in AMERISOURCEBERGEN CORPORATION |
| 07/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/14/2023 |
8-K
| Quarterly results |
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
SC 13D/A
| Walgreens Boots Alliance, Inc. reports a 0% stake in Option Care Health, Inc. |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/15/2023 |
SC 13D/A
| Walgreens Boots Alliance, Inc. reports a 16.5% stake in AMERISOURCEBERGEN CORPORATION |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/28/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/21/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/21/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"Consent of PricewaterhouseCoopers LLP, independent auditor of Summit Health-CityMD",
"Summit Health-CityMD Audited Consolidated Financial Statements as of December 31, 2021 and for the year ended December 31, 2021",
"Summit Health-CityMD Unaudited Condensed Consolidated Financial Statements as of and for the nine months ended September 30, 2022",
"Unaudited Pro Forma Condensed Combined Financial Information consisting of the Unaudited Pro Forma Condensed Combined Balance Sheet as of November 30, 2022, the Unaudited Pro Forma Condensed Combined Statement of Earnings for the year ended August 31, 2022 and the Unaudited Pro Forma Condensed Combined Statement of Earnings for the three months ended November 30, 2022" |
|
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
SC 13G/A
| STATE STREET CORP reports a 6.7% stake in AMENDED FILING WALGREENS BOOTS ALLIANCE INC |
| 01/31/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7% stake in WALGREENS BOOTS ALLIANCE INC |
| 01/05/2023 |
10-Q
| Quarterly Report for the period ended November 30, 2022 |
| 01/05/2023 |
8-K
| Quarterly results |
| 01/05/2023 |
8-K
| Quarterly results |
| 12/20/2022 |
8-K
| Quarterly results |
| 12/12/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/08/2022 |
144
| Form 144 - Report of proposed sale of securities: |
| 12/08/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/08/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 12/07/2022 |
8-K
| Quarterly results |
| 11/23/2022 |
8-K/A
| Quarterly results |
| 11/23/2022 |
10-K/A
| Annual Report for the period ended August 31, 2022 [amend] |
|